1.    Zulaika-Lloret M, Rodriguez-Troncoso M, Ruiz-Villaverde R. OX40: A promising therapeutic target in moderate-to-severe atopic dermatitis. Actas Dermosifiliogr. 2024 Dec 31:S0001-7310(24)01054-8. English, Spanish. doi: 10.1016/j.ad.2024.06.014. Epub ahead of print. PMID: 39746650.
2.    Zulaika-Lloret M, Gil-Villalba A, Cebolla-Verdugo M, Ruiz-Villaverde R. Metástasis en coraza de adenocarcinoma de próstata [Prostate adenocarcinoma cutaneous metastasis]. Rev Esp Geriatr Gerontol. 2024 Dec 16;60(2):101580. Spanish. doi: 10.1016/j.regg.2024.101580. Epub ahead of print. PMID: 39689441.
3.    Medina-Cobos A, Cabrerizo-Carvajal A, Ruiz-Villaverde R. Escombroidosis. Un diagnóstico a considerar [Scombroidosis. A diagnosis to consider]. Semergen. 2024 Dec 9;51(3):102352. Spanish. doi: 10.1016/j.semerg.2024.102352. Epub ahead of print. PMID: 39657571.
4.    Rodríguez-Troncoso M, Vargas-Castillo G, Ruiz-Villaverde R. Úlceras submamarias de etiología yatrogénica. ¿Las sospechamos adecuadamente? [Iatrogenic submammary ulcers. Do we suspect them correctly?]. Semergen. 2024 Dec 9;51(3):102397. Spanish. doi: 10.1016/j.semerg.2024.102397. Epub ahead of print. PMID: 39657568.
5.    Marfil-Cantón M, Prados-Carmona A, Cebolla-Verdugo M, Husein-ElAhmed H, Campos F, Ruiz-Villaverde R. Anti-OX40 Biological Therapies in the Treatment of Atopic Dermatitis: A Comprehensive Review. J Clin Med. 2024 Nov 17;13(22):6925. doi: 10.3390/jcm13226925. PMID: 39598069; PMCID: PMC11594770.
6.    Moreno-Suárez FG, Labrot-Moreno Moleón IL, Ruiz-Villaverde R. [Translated article] Trigeminal Trophic Syndrome: A Diagnosis to Be Kept in Mind. Actas Dermosifiliogr. 2024 Nov 19:S0001-7310(24)00900-1. English, Spanish. doi: 10.1016/j.ad.2024.11.010. Epub ahead of print. PMID: 39566735.
7.    Peris-Espino V, Munera-Campos M, Chicharro P, González Quesada A, Flórez Menéndez Á, de la Cueva Dobao P, Giménez Arnau AM, Gilaberte Calzada Y, Rodríguez Serna M, Montero-Vilchez T, Silvestre Salvador JF, Ruiz-Villaverde R, Elosua-González M, Del Alcázar-Viladomiu E, Sánchez-Pérez J, Carretero Hernández G, Batalla A, Suh Oh HJ, Couselo-Rodríguez C, Mauleón Fernández C, Curto-Barredo L, Bertolín-Colilla M, Navarro-Bielsa A, Ballano Ruiz A, Botella Estrada R, Arias-Santiago S, Sanabria-de-la-Torre R, Betlloch-Mas I, Navarro-Triviño FJ, Roustan Gullón G, Rosell-Díaz A, Loro-Pérez M, Suárez-Pérez J, García-Doval I, Descalzo-Gallego MÁ, Carrascosa Carrillo JM. Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP Registry. Actas Dermosifiliogr. 2024 Nov 13:S0001-7310(24)00892-5. English, Spanish. doi: 10.1016/j.ad.2024.09.019. Epub ahead of print. PMID: 39547487.
8.    Ruiz-Villaverde R, Cebolla-Verdugo M, Prados-Carmona A, Pereyra Rodríguez JJ, Armario-Hita JC. Mechanism, Diagnostic and Therapeutic Novelties in Dermatology: Where Are We Going? Life (Basel). 2024 Sep 27;14(10):1236. doi: 10.3390/life14101236. PMID: 39459536; PMCID: PMC11508715.
9.    Pegalajar-García MD, Ayén-Rodriguez A, Almazán-Fernández FM, Ruiz-Villaverde R. [Translated article] Five-Case Report Series of Dermofat Graft in Nasal Alar Surgical Defect Reconstruction. Actas Dermosifiliogr. 2024 Nov- Dec;115(10):T1047-T1048. English, Spanish. doi: 10.1016/j.ad.2024.10.054. Epub 2024 Oct 23. PMID: 39454862.
10.    Navarro-Triviño FJ, Galán-Gutiérrez M, Pereyra-Rodríguez JJ, Ruiz-Villaverde R. [Translated article] Real-World Safety and Efficacy Profile of Baricitinib in Patients With Atopic Dermatitis: a Multicenter Retrospective Trial From Four Spanish Hospitals in Andalusia. Actas Dermosifiliogr. 2024 Nov- Dec;115(10):T1054-T1057. English, Spanish. doi: 10.1016/j.ad.2024.10.053. Epub 2024 Oct 23. PMID: 39454859.
11.    Armario-Hita JC, Pereyra-Rodriguez JJ, González-Quesada A, Herranz P, Suarez R, Galan-Gutiérrez M, Rodríguez-Serna M, Ortiz de Frutos J, Carrascosa JM, Serra-Baldrich E, Ara-Martin M, Figueras-Nart I, Silvestre JF, Zaragoza-Ninet V, Ruiz-Villaverde R. Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study. Int J Dermatol. 2024 Nov;63(11):e289-e295. doi: 10.1111/ijd.17344. Epub 2024 Jun 21. PMID: 39425593.
12.    Silvestre JF, Ruiz-Villaverde R, Pérez-García B, Herranz Pinto P, Domínguez- Cruz JJ, Gentile M, Izu Belloso RM. [Translated article] Real-World Clinical, Psychosocial and Financial Burden of Atopic Dermatitis: Results from the Spanish Cohort of the MEASURE-AD Trial. Actas Dermosifiliogr. 2025 Jan;116(1):T5-T14. English, Spanish. doi: 10.1016/j.ad.2024.10.015. Epub 2024 Oct 10. PMID: 39393603.
13.    Vargas-Castillo G, Zulaika-Lloret M, Ruiz-Villaverde R. Policondritis recidivante [Relapsing polychondritis]. Aten Primaria. 2025 Jan;57(1):103086. Spanish. doi: 10.1016/j.aprim.2024.103086. Epub 2024 Sep 19. PMID: 39303652; PMCID: PMC11437755.
14.    Gómez-Martín EM, Llamas-Molina JM, Ruiz-García ME, Velasco-Amador JP, Ruiz- Villaverde R. The effectiveness of punch grafts in promoting the healing of surgical injuries and hard-to-heal wounds. Br J Nurs. 2024 Aug 13;33(15):S28-S32. doi: 10.12968/bjon.2024.0082. PMID: 39141340.
15.    Cebolla-Verdugo M, Gómez-Valcárcel JJ, Ruiz-Villaverde R. sQUIZ your knowledge! Unravelling dermatological enigmas: a puzzling case of a cutaneous anomaly on the popliteal region of a 12-year-old boy. Eur J Dermatol. 2024 Jun 1;34(3):344-346. doi: 10.1684/ejd.2024.4719. PMID: 39015991.
16.    Prados-Carmona A, Moyano-Bueno D, Ruiz-Villaverde R. sQUIZ your knowledge! Fever and painful recurrent subcutaneous nodules. Eur J Dermatol. 2024 Apr 1;34(2):244-246. doi: 10.1684/ejd.2024.4674. PMID: 38907576.
17.    Zulaika-Lloret M, Llamas-Molina JM, Ruiz-Villaverde R. sQuiz your knowledge! A pale and indurated nodule on the ala of the nose. Eur J Dermatol. 2024 Apr 1;34(2):241-242. doi: 10.1684/ejd.2024.4672. PMID: 38907574.
18.    Ayén-Rodríguez Á, Gil-Villalba A, Ruiz-Villaverde R, Navarro-Triviño FJ. [Translated article] Methotrexate Toxicity in Dermatological Patients. Actas Dermosifiliogr. 2024 Jul-Aug;115(7):T741-T743. English, Spanish. doi:10.1016/j.ad.2024.05.009. Epub 2024 May 28. PMID: 38815680.
19.    De la Torre-Gomar FJ, Llamas-Molina JM, Pegalajar-García MD, Pérez-Valencia C, Carrero-Castaño A, Ruiz-Villaverde R. Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination-What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature. Life (Basel). 2024 Mar 14;14(3):386. doi: 10.3390/life14030386. PMID: 38541710; PMCID: PMC10971988.
20.    Rodríguez-Troncoso M, Llamas-Molina JM, Benavente-Fernández A, Narváez-Simón M, Ruiz-Villaverde R. Splinter haemorrhages in a patient with systemic mastocytosis and hypereosinophilia. Br J Haematol. 2024 Jun;204(6):2149-2150. doi: 10.1111/bjh.19349. Epub 2024 Mar 12. PMID: 38471752.
21.    Saenz-Guirado S, Ayen-Rodriguez A, Galvez-Moreno M, Velasco-Amador JP, Llamas-Molina JM, Ruiz-Villaverde R, Molina-Leyva A. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study. Photodiagnosis Photodyn Ther. 2024 Apr;46:104031. doi: 10.1016/j.pdpdt.2024.104031. Epub 2024 Mar 2. PMID: 38438001.
22.    Aguado Vázquez Á, Estébanez Corrales A, Melgosa Ramos FJ, Mascaró Galy JM, Fulgencio-Barbarin J, Bosch Amate X, Curto Barredo L, Blanes-Martínez M, Ruiz- Villaverde R, Ballester Martínez A, Martín-Torregrosa D, Castaño Fernández JL, Cabeza Martínez R, Pérez-Ferriols A, Ramos Rodríguez D, Boix Vilanova J, Melé- Ninot G, Expósito Serrano V, España Alonso A, Mateu-Puchades A. Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real- world experience. Clin Exp Dermatol. 2024 Aug 22;49(9):1002-1006. doi:10.1093/ced/llae067. PMID: 38430106.
23.    Montero-Menárguez J, Amat Samaranch V, Puig Sanz L, Ruiz-Villaverde R, Arias-Santiago S, Larrea García M, Ruiz Genao D, Ferrán M, Schneller-Pavelescu L, Romero Ferreiro C, Rivera Díaz R. Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients. Actas Dermosifiliogr. 2024 Sep;115(8):761-765. English, Spanish. doi: 10.1016/j.ad.2024.02.019. Epub 2024 Feb 22. PMID: 38401879.
24.    Moreno-Suárez FG, Labrot-Moreno Moleón IL, Ruiz-Villaverde R. Trigeminal Trophic Syndrome: A Diagnosis to Be Kept in Mind. Actas Dermosifiliogr. 2024 Feb 17:S0001-7310(24)00149-2. English, Spanish. doi: 10.1016/j.ad.2023.09.028. Epub ahead of print. PMID: 38369279.
25.    Lopez-Garzon M, López-Fernández MD, Ruíz-Martínez AM, Galván-Banqueri P, Lozano-Lozano M, Tovar-Martín I, Postigo-Martin P, Ariza-Vega P, Artacho-Cordón F, Fernández-Lao C, Cantarero-Villanueva I, Fernández-Gualda MÁ, Arroyo-Morales M, Ruíz-Villaverde R, Galiano-Castillo N. Efficacy of photobiomodulation therapy combined with mobile health education in patients with head and neck cancer suffering from chronic xerostomia after radiotherapy: protocol for a three-arm, randomised, placebo-controlled, double-blinded study. BMJ Open. 2024 Jan 24;14(1):e078068. doi: 10.1136/bmjopen-2023-078068. PMID: 38267245; PMCID: PMC10824058.
26.    Cebolla-Verdugo M, Llamas-Segura C, Linares-González L, Ruiz-Villaverde R, Navarro-Triviño FJ. A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiency. J Dermatolog Treat. 2024 Dec;35(1):2307495. doi: 10.1080/09546634.2024.2307495. Epub 2024 Jan 23. PMID:38258513.
27.    Sánchez-Díaz M, Flórez Á, Ara-Martín M, Arias-Santiago S, Botella-Estrada R, Cañueto J, Carretero-Hernández G, Coto-Segura P, de Eusebio-Murillo E, García- Latasa de Araníbar FJ, García-Patos Briones V, Gardeazabal García J, Gómez- Fernández C, Hernández-Ostiz S, Izu Belloso R, López-Ávila A, Manchado López P, Martín-Santiago A, Martinez de Espronceda Ezquerro I, Mateu-Puchades A, Mercader-García P, Notario Rosa J, Palacio Aller L, Pérez-Hortet C, Quintana- Castanedo L, Rivera R, Rocamora Duran V, Rodríguez-Nevado IM, Ruiz-Villaverde R, Suárez J, Trasobares-Marugán L, Vizán-de Uña C, Yanguas I, Zulaica-Garate A, García-Doval I, Descalzo MÁ, Grau-Pérez M, Carrascosa-Carrillo JM. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study. Actas Dermosifiliogr. 2024 Mar;115(3):T237-T245. English, Spanish. doi: 10.1016/j.ad.2024.01.019. Epub 2024 Jan 17. PMID: 38242435.
28.    Cebolla-Verdugo M, Cabrerizo-Carvajal A, Ruiz-Villaverde R. Dermatosis glútea senil [Senile gluteal dermatosis]. Semergen. 2024 Apr;50(3):102130. Spanish. doi: 10.1016/j.semerg.2023.102130. Epub 2023 Nov 17. PMID: 37980782.
29.    Prados-Carmona A, Remón-Love A, Ruiz-Villaverde R. Black-purplish nodules on skin: a time-sensitive finding. J Dtsch Dermatol Ges. 2024 Jan;22(1):126-127. doi: 10.1111/ddg.15295. Epub 2023 Nov 5. PMID: 37926837.
30.    Navarro-Triviño FJ, Galán-Gutiérrez M, Hita JC, Ruiz-Villaverde R, Domínguez-Cruz J, Pereyra-Rodríguez JJ. Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up. Dermatitis. 2024 Jan- Feb;35(S1):S55-S61. doi: 10.1089/derm.2023.0220. Epub 2023 Oct 26. PMID:37883648.
31.    Prados-Carmona A, Ruiz-Villaverde R, Navarro-Triviño FJ. Could baricitinib be a safe and effective therapeutic alternative for incoercible pruritus in patients with dermatitis herpetiformis? Int J Dermatol. 2024 Jan;63(1):e24-e26. doi: 10.1111/ijd.16878. Epub 2023 Oct 11. PMID: 37818765.
32.    Galván Casas C, Ruiz-Villaverde R, Prados-Carmona Á, Fernández Camporro Á, Angulo Menéndez AG, Álvarez-Buylla Puente MC, Pasquali P, Aguado Vázquez Á, Masferrer E, Rodríguez González L, Ruiz-Sánchez D, Caballero-Linares CF, Tejera- Vaquerizo A, Iglesias-Pena N, Fernández de Piérola S, Maldonado-Seral C, Armengot-Carbó M, Alonso-Naranjo L, Barros Tornay R, Solano Novo T, Fernández Tapia V, Martín-Gorgojo A, Adsuar Mas J, Parera Amer ME, Pérez Feal P, Taberner R, Utrera-Busquets M, Vicente Sánchez I, Palacio Aller L, Sánchez-Gutiérrez I, Usero-Bárcena T, Aldea Manrique B, Sánchez Velázquez A, Martínez García E, Grau-
33.    Pérez M, García-Doval I; CLINI-AEDV. Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement - A Multicenter Cross-Sectional CLINI-AEDV Study. Actas Dermosifiliogr. 2024 Jan;115(1):36-47. English, Spanish. doi:10.1016/j.ad.2023.08.006. Epub 2023 Sep 9. PMID: 37678633.
34.    Couselo-Rodríguez C, Batalla A, Carrascosa JM, Chicharro P, González-Quesada A, de la Cueva P, Giménez-Arnau AM, Gilaberte Y, Rodríguez-Serna M, Montero- Vilchez T, Ruiz-Villaverde R, Elosua-González M, Silvestre-Salvador JF, Munera- Campos M, Sánchez-Pérez J, Carretero G, Mauleón-Fernández C, Curto-Barredo L, Ballano-Ruiz A, Botella-Estrada R, Arias-Santiago S, Navarro-Triviño FJ, Roustan-Gullón G, Betlloch I, Del Alcázar E, Abalde-Pintos MT, Suárez-Perez J, García-Doval I, Descalzo MÁ, Flórez Á. Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). Actas Dermosifiliogr. 2024 Apr;115(4):341-346. English, Spanish. doi: 10.1016/j.ad.2023.07.014. Epub 2023 Jul 22. PMID:37482292.
35.    de la Torre Gomar FJ, Gimeno Castillo J. Un arcoíris entre las colinas [A rainbow among the hills]. Semergen. 2024 Mar;50(2):102091. Spanish. doi: 10.1016/j.semerg.2023.102091. Epub 2023 Nov 3. PMID: 37925999.
36.    Ayén-Rodríguez A, Sánchez-Díaz M, Grau-Pérez M, García-Doval I, Descalzo MA. Bibliometric Study of the Advances Made in Clinical Dermatological Research in Spain from 2015 through 2021: Update of the MaIND Project and Interactive Online Map. Actas Dermosifiliogr. 2024 Nov-Dec;115(10):948-956. English, Spanish. doi: 10.1016/j.ad.2024.05.002. Epub 2024 May 23. PMID: 38795842.
37.    Navarro-Triviño FJ, Guerrero Fernández de Alba I. [Translated article] Link Between Dermatology and Preventive Medicine: Has the Shingles Vaccination Changed the Overall Landscape? Actas Dermosifiliogr. 2025 Jan;116(1):T1-T4. English, Spanish. doi: 10.1016/j.ad.2024.10.014. Epub 2024 Oct 10. PMID:39393604.

38.    Pegalajar-García MD, Pérez-López I, Navarro-Triviño FJ. [Translated article] Erythematous nodule on the upper lip. Actas Dermosifiliogr. 2024 Oct;115(9):T913-T914. English, Spanish. doi: 10.1016/j.ad.2024.08.004. Epub 2024 Aug 3. PMID: 39102981.

 

1.    Gil-Villalba A, Ayén-Rodríguez Á, Naranjo-Díaz MJ, Linares-González L, Ruiz- Villaverde R. Efficacy of Fractional CO₂ Laser Therapy in Improving Symptoms and Quality of Life in Women with Refractory Vulvar Lichen Sclerosus: A Prospective Observational Study. Life (Basel). 2024 Dec 18;14(12):1678. doi: 10.3390/life14121678. PMID: 39768385; PMCID: PMC11728231.

1.    Colmenero-Sendra M, Del Boz-González J, Grau-Pérez M, Ruiz-Villaverde R, Descalzo-Gallego MÁ, García-Doval I, Baselga Torres E. Interobserver and Intraobserver Agreement on the Treatment of Infantile Hemangiomas. JAMA Dermatol. 2024 Dec 18. doi: 10.1001/jamadermatol.2024.5125. Epub ahead of print. PMID: 39693091.
2.    Pérez-López I, Garrido-Colmenero C, Ruiz-Villaverde R. [Translated article] Recurrent Rash on the Left Side of the Face: A Diagnostic Challenge. Actas Dermosifiliogr. 2024 Nov-Dec;115(10):T987-T988. English, Spanish. doi: 10.1016/j.ad.2024.09.005. Epub 2024 Sep 12. PMID: 39260606.
3.    Velasco-Amador JP, Pérez-López I, Ruiz-Villaverde R. Bead-like lesion at perineal region. An Pediatr (Engl Ed). 2024 Jun;100(6):e5-e6. doi: 10.1016/j.anpede.2024.02.008. Epub 2024 Mar 1. PMID: 38431449.
4.    Pérez-López I, Herrera García JD, Ayén Rodríguez A, Ruiz-Villaverde R. Bilateral Temporal Arachnoid Cysts Associated With Phakomatosis Cesioflammea. Actas Dermosifiliogr. 2024 Apr;115(4):425-426. English, Spanish. doi: 10.1016/j.ad.2022.10.052. Epub 2023 Jul 22. PMID: 37482295.
 

1.    Ródenas-Herranz T, Rodriguez-Barranco M, Petrova D, Pérez-Gómez B, Ruiz- Villaverde R, Sánchez MJ. Trends in incidence, mortality, and survival of cutaneous malignant melanoma over three decades: a population-based study in Southern Spain. Clin Exp Dermatol. 2024 Nov 22:llae516. doi: 10.1093/ced/llae516. Epub ahead of print. PMID: 39576024.
2.    Cebolla-Verdugo M, Llamas-Segura C, Velasco-Amador JP, Almazán-Fernández FM, Ruiz-Villaverde R. Understanding and managing locally advanced basal cell carcinoma: insights into pathogenesis, therapeutic strategies, and the role of hedgehog pathway inhibitors. Ital J Dermatol Venerol. 2024 Oct;159(5):530-542. doi: 10.23736/S2784-8671.24.07993-3. PMID: 39422527.
3.    Cebolla-Verdugo M, Moyano-Bueno D, Prados-Carmona Á, Ruiz-Villaverde R. Unusual genital lesion mimicking squamous cell carcinoma: A diagnostic challenge. Enferm Infecc Microbiol Clin (Engl Ed). 2024 Oct 9:S2529-993X(24)00213-2. doi: 10.1016/j.eimce.2024.10.004. Epub ahead of print. PMID: 39389797.
4.    Naranjo Díaz MJ, Ródenas-Herranz T, Espadafor-Lopez B, Ruiz-Villaverde R. Satisfactory Response to Pulsed Dye Laser Treatment of Facial Erythema in a Patient with Amyopathic Dermatomyositis. Actas Dermosifiliogr. 2024 Mar;115(3):326-327. English, Spanish. doi: 10.1016/j.ad.2022.08.020. Epub 2022 Sep 14. PMID: 36115383.
5.    Tejera-Vaquerizo A, Gómez-Tomás Á, Jaka A, Toll A, Del Río M, Ferrándiz- Pulido C, Fuente MJ, Carrasco C, Almazán-Fernández FM, Toledo-Pastrana T, Ferrer-Fuertes A, Ribero S, Avallone G, Cañueto J, Santos-Juanes J, Sanmartín O. Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study. J Eur Acad Dermatol Venereol. 2024 Aug;38(8):1588-1598. doi: 10.1111/jdv.20051. Epub 2024 May 13. PMID: 38738666.
6.    Peña-Martín J, Belén García-Ortega M, Palacios-Ferrer JL, Díaz C, Ángel García M, Boulaiz H, Valdivia J, Jurado JM, Almazan-Fernandez FM, Arias Santiago S, Vicente F, Del Val C, Pérez Del Palacio J, Marchal JA. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study. Br J Dermatol. 2024 Apr 17;190(5):740-750. doi:10.1093/bjd/ljae013. PMID: 38214572.

1.    Llamas-Segura C, Cebolla-Verdugo M, Velasco-Amador JP, Ruiz-Villaverde R, Navarro-Triviño FJ. Guarding the goal: A case study on allergic contact dermatitis in a young football goalkeeper's hand. Contact Dermatitis. 2024 Sep;91(3):263-264. doi: 10.1111/cod.14590. Epub 2024 May 19. PMID: 38764174.
2.    Velasco-Amador JP, Prados-Carmona Á, Ruiz-Villaverde R, Navarro-Triviño FJ. Lingual lichenoid allergic contact dermatitis: Two cases reported. Contact Dermatitis. 2024 Jul;91(1):79-81. doi: 10.1111/cod.14554. Epub 2024 Mar 29. PMID: 38553431.
3.    Pesqué D, Planella-Fontanillas N, Borrego L, Sanz-Sánchez T, Zaragoza-Ninet V, Serra-Baldrich E, Miquel-Miquel FJ, Silvestre-Salvador JF, Córdoba-Guijarro S, Sánchez-Gilo A, Mercader-García P, Navarro-Triviño FJ, Ortiz-de-Frutos FJ, Tous-Romero F, Rodríguez-Serna M, Melé-Ninot G, Barrabés-Torrella C, Ruiz- González I, Pastor-Nieto MA, Carrascosa-Carrillo JM, Gómez-de-la-Fuente E, Sánchez-Pedreño-Guillén P, Sánchez-Pérez J, Pereyra-Rodríguez JJ, Gatica-Ortega ME, González-Pérez R, Pujol RM, Descalzo MÁG, García-Doval I, Giménez-Arnau AM. Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023. Contact Dermatitis. 2025 Feb;92(2):120-130. doi: 10.1111/cod.14702. Epub 2024 Oct 12. PMID:39394969; PMCID: PMC11710926.
4.    Chong AC, Navarro-Triviño FJ, Su M, Park CO. Fungal Head and Neck Dermatitis: Current Understanding and Management. Clin Rev Allergy Immunol. 2024 Jun;66(3):363-375. doi: 10.1007/s12016-024-09000-7. Epub 2024 Jul 20. PMID: 39031274; PMCID: PMC11422441.
5.    Mercader-García P, Silvestre JF, Navarro-Triviño FJ, Giménez-Arnau AM, Pastor-Nieto MA, Cordoba-Guijarro S, Melé-Ninot G, Tous-Romero F, González-Pérez R, Ruiz-González I, Sánchez-Pérez J, Gática-Ortega ME, Sánchez-Pedreño P, Miquel-Miquel J, Ortiz-Frutos J, Carrascosa JM, Serra-Baldrich E, Sanz-Sánchez T, Soria-Aledo V, Carrillo A, Borrego L; REIDAC. A re-assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight. Contact Dermatitis. 2024 Sep;91(3):228-236. doi: 10.1111/cod.14639. Epub 2024 Jul 4. PMID: 38965446.
6.    Sanz-Cabanillas EB, de Dulanto-García L, Prados-Carmona Á, Navarro-Triviño FJ. Comment response in: 'Systemic allergic contact dermatitis after use of topical nitrofurazone'. Contact Dermatitis. 2024 Sep;91(3):269. doi: 10.1111/cod.14634. Epub 2024 Jul 4. PMID: 38963169.
7.    Navarro-Triviño FJ, Borrego L, Silvestre-Salvador JF, Mercader-García P, Giménez-Arnau AM, Ortiz-de Frutos FJ, Sanz-Sánchez T, Melé-Ninot G, Sánchez-Gilo A, Zaragoza-Ninet V, Serra-Baldrich E, Miquel-Miquel J, Córdoba-Guijarro S, Rodríguez-Serna M, Ruíz-González I, Carrascosa-Carrillo JM, Gómez-de la Fuente E, Pastor-Nieto MA, Heras-Mendaza F, González-Pérez R, Sánchez-Pedreño Guillén P, Sánchez-Pérez J, Gatica-Ortega ME, Fernández-Redondo V, Hervella-Garcés M, Manrique-Martínez P, Guimaraens-Juanena D, García-Gavín J, Giménez-Arnau E, Figueras-Nart I, Curto-Barredo L, Armario-Hita JC. [Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). Actas Dermosifiliogr. 2024 Jul- Aug;115(7):T712-T721. English, Spanish. doi: 10.1016/j.ad.2024.05.018. Epub 2024 May 31. PMID: 38823769.
8.    Pegalajar-García MD, Coronel-González BA, Navarro-Triviño FJ. [Translated article] Allergic Contact Dermatitis to Topical Ophthalmic Drugs: Review of Frequently Used Allergens in Spain. Actas Dermosifiliogr. 2024 Jun;115(6):T572-T582. English, Spanish. doi: 10.1016/j.ad.2024.04.015. Epub 2024 Apr 20. PMID: 38648926.
9.    Navarro-Triviño FJ, Salazar-Nievas M, Sanz-Cabanillas JL, Arjona-Aguilera C. Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients. Australas J Dermatol. 2024 May;65(3):260-265. doi: 10.1111/ajd.14264. Epub 2024 Apr 8. PMID: 38587232.
10.    Sanz-Cabanillas EB, de Dulanto-García L, Prados-Carmona A, Navarro-Triviño FJ. Systemic allergic contact dermatitis after use of topical nitrofurazone. Contact Dermatitis. 2024 Aug;91(2):154-156. doi: 10.1111/cod.14560. Epub 2024 Apr 5. PMID: 38577948.
11.    Velasco-Amador JP, Prados-Carmona Á, Navarro-Triviño FJ. If not angioedema, what is it? Diagnostic approach to facial edema. J Dtsch Dermatol Ges. 2024 Apr;22(4):501-512. doi: 10.1111/ddg.15336. Epub 2024 Mar 14. PMID: 38483055.
12.    Velasco-Amador JP, Prados-Carmona Á, Navarro-Triviño FJ. [Translated article] Medical Devices in Patients With Diabetes and Contact Dermatitis. Actas Dermosifiliogr. 2024 Mar;115(3):T280-T287. English, Spanish. doi: 10.1016/j.ad.2024.01.016. Epub 2024 Jan 17. PMID: 38242434
 

1.    Martorell-Calatayud A, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Díaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran- Farrés M, Gallardo-Hernández F, Almenara-Blasco M, Suarez-Perez JA, González- Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, Del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Ara-Martín M, Mateu-Puchades A, Llamas- Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study. Actas Dermosifiliogr. 2024 Oct 23:S0001-7310(24)00854-8. English, Spanish. doi: 10.1016/j.ad.2024.10.042. Epub ahead of print. PMID: 39454868.
2.    Carretero Hernández G, Ara Martín M, Armesto Alonso S, Belinchón Romero I, Eiris Salvado N, Ferrán Farrés M, Galache Osuna C, García Bustínduy M, García Latasa de Araníbar J, Juliá Manresa M, Llamas Velasco M, López Ferrer A, Roncero Riesco M, Ruiz Genao D, Ruíz-Villaverde R, Salgado Boquete L, Soria Martínez C, Vilarrasa Rull E, Descalzo MA; AEDV Psoriasis Group. [Translated article] Measurement Assessment of Minimal Disease Activity in Psoriasis in Spain: A National Cross-Sectional Study. Actas Dermosifiliogr. 2025 Jan;116(1):T21-T30.English, Spanish. doi: 10.1016/j.ad.2024.10.009. Epub 2024 Oct 9. PMID:39389350.
3.    Ceravalls J, Ruiz-Villaverde R, Armesto S, Fernández-Armenteros JM, Riera- Monroig J, Gracia-Cazaña T, Quintana-Codina M, Iglesias-Sancho M, Salleras M, Moya AI, Melgosa Ramos FJ, Ferran M. Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicentre study. J Eur Acad Dermatol Venereol. 2024 Sep 13. doi: 10.1111/jdv.20346. Epub ahead of print. PMID: 39269142.
4.    Butrón-Bris B, Llamas-Velasco M, Ovejero-Benito MC, Santos-Juanes J,Martínez-López A, Ruiz-Villaverde R, Roustan G, Baniandrés O, Izu-Belloso R, de la Cueva P, Sahuquillo-Torralba A, Gónzalez-Quesada A, Vilarrasa-Rull E, Pujol-Montcusí J, García-Martínez J, Navares M, Palomar-Moreno I, Novalbos J, Abad-Santos F, Daudén E, de la Fuente H. Genetic polymorphisms to identify patientswith an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice. Exp Dermatol. 2024 Aug;33(8):e15152. doi: 10.1111/exd.15152.PMID: 39081053; PMCID: PMC11605493.
5.    Puig L, Izu Belloso R, Rivera-Díaz R, Mollet Sánchez J, Rodríguez Fernández-Freire L, Sahuquillo-Torralba A, Ruiz-Villaverde R; IMPULSE investigators group.A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics,Clinical Characteristics, and Management of Generalized Pustular PsoriasisPatients in Spain: IMPULSE Study. Dermatology. 2024;240(5-6):778-792. doi:10.1159/000540019. Epub 2024 Jul 17. PMID: 39019021; PMCID: PMC11651324.
6.    Daudén E, Belinchón I, Colominas-González E, Coto P, de la Cueva P, Gallardo F, Poveda JL, Ramírez E, Ros S, Ruíz-Villaverde R, Comellas M, Lizán L. Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients. Sci Rep. 2024 Jun 24;14(1):14519. doi: 10.1038/s41598-024-64738-6. PMID: 38914574; PMCID: PMC11196587.
7.    Bizzarri F, Ruiz-Villaverde R, Morales-Garrido P, Ruiz-Carrascosa JC, Cebolla-Verdugo M, Prados-Carmona A, Rodriguez-Troncoso M, Raya-Alvarez E. JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice. Diagnostics (Basel). 2024 May 8;14(10):988. doi: 10.3390/diagnostics14100988. PMID: 38786286; PMCID: PMC11119658
8.    Sahuquillo-Torralba A, Mansilla-Polo M, Pujol-Marco C, Llamas-Velasco M, Rull EV, Ruiz Villaverde R, Ferran M, Pitarch G, Lopez A, Beltran E, Urruticoechea-Arana A, Riera-Monroig J, Alsina M, Vidal D, Belinchón Romero I, Notario J, Carrascosa JM, Gonzalez-Delgado V, Mollet J, Ribera M, Gallardo F. Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective ana ysis in daily clinical practice by the Spanish Psoriasis Group. Int J Dermatol. 2024 Dec;63(12):1720-1727. doi:10.1111/ijd.17238. Epub 2024 May 12. PMID: 38736107.
9.    Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Cebolla-Verdugo M, Prados- Carmona A, Hernández-Montoya C, Armario-Hita JC, Galán-Gutiérrez M. Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain. Life (Basel). 2024 Feb 20;14(3):281. doi: 10.3390/life14030281. PMID: 38541607; PMCID: PMC10971645
10.    Martorell A, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Díaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran- Farrés M, Gallardo-Hernández F, Almenara-Blasco M, Suarez-Perez JA, González- Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, Del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Ara-Martín M, Mateu-Puchades A, Llamas- Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study. Actas Dermosifiliogr. 2024 Mar 6:S0001-7310(24)00187-X. English, Spanish. doi: 10.1016/j.ad.2024.02.030. Epub ahead of print. PMID: 38452889.
11.    Muñoz-Aceituno E, Butrón-Bris B, Ovejero-Benito MC, Sahuquillo-Torralba A, Baniandrés Rodríguez O, Herrera-Acosta E, Rivera-Diaz R, Ferran M, Sánchez- Carazo JL, Riera-Monroig J, Pujol-Montcusí J, Vidal D, de la Cueva P, García- Bustinduy M, Ruiz-Villaverde R, Ballescà F, Llamas-Velasco M, Navares M, Palomar-Moreno I, Sánchez-García I, García-Martínez J, Novalbos J, Zubiaur P, Abad-Santos F, Daudén-Tello E, de la Fuente H. Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1783-1790. doi: 10.1111/jdv.19782. Epub 2023 Dec 28. PMID: 38153843.
12.    Ruiz-Villaverde R, Galan-Gutierrez M, Armario-Hita JC, Rodriguez-Fernandez- Freire L. Efficacy and Pharmacoeconomic Analysis in Real Clinical Practice Conditions of Patients with Plaque Psoriasis Treated with Guselkumab: A Retrospective Multicenter Study. Actas Dermosifiliogr. 2024 Mar;115(3):321-323. English, Spanish. doi: 10.1016/j.ad.2023.10.023. Epub 2023 Nov 2. PMID: 37923077.
13.    Jiménez Gómez N, González-Cantero Á, Ruiz-Villaverde R, Llamas-Velasco M, de la Cueva Dobao P, Rivera Díaz R, Martínez Lorenzo E, Alonso Pacheco ML, Baniandrés Rodríguez O, Mollet Sánchez J, Pitarch Bort G, Izu Belloso RM, Jaén Olasolo P. Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study. Actas Dermosifiliogr. 2024 Jan;115(1):10-20. English, Spanish. doi: 10.1016/j.ad.2023.06.015. Epub 2023 Jul 11. PMID:37442420.

 

1.    De la Torre-Gomar FJ, Velasco-Amador JP, Prados-Carmona Á, Ruiz-Villaverde R. Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib. J Dermatolog Treat. 2024 Dec;35(1):2304630. doi: 10.1080/09546634.2024.2304630. Epub 2024 Jan 19. PMID: 38240097
2.    Lobato-Berezo A, Escolà-Rodríguez A, Courtney A, Chim I, Ruiz-Villaverde R, Imbernón-Moya A, Velasco-Tamariz V, Vañó-Galván S, Gil-Redondo R, Del Boz J, Garnacho Saucedo G, Starace M, Saceda-Corralo D, Quadrelli F, Piraccini BM, Pujol RM. Acne keloidalis nuchae: An international multicentric review of 79 patients. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):e342-e345. doi: 10.1111/jdv.19609. Epub 2023 Nov 9. PMID: 37909243.

 

ESTUDIOS OBSERVACIONALES 2024

Unidad de Terapia Fotodinámica

Terapia Fotodinámica convencional vs Terapia Fotodinámica Luz de Día + Terapia Fotodinámica Convencional
Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio
FEA. Soledad Saénz Guirado 

Publicaciones:

1: Saenz-Guirado S, Ayen-Rodriguez A, Galvez-Moreno M, Velasco-Amador JP,
Llamas-Molina JM, Ruiz-Villaverde R, Molina-Leyva A. Home- vs clinic-based
daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200
ALA) for actinic keratosis: A randomized, single-blind, prospective study.
Photodiagnosis Photodyn Ther. 2024 Mar 2;46:104031. doi:
10.1016/j.pdpdt.2024.104031. Epub ahead of print. PMID: 38438001.

2: Sáenz-Guirado S, Cuenca-Barrales C, Vega-Castillo J, Linares-Gonzalez L,
Ródenas-Herranz T, Molina-Leyva A, Ruiz-Villaverde R. Combined versus
conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion
(BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective
study. Photodermatol Photoimmunol Photomed. 2022 Jul;38(4):334-342. doi:
10.1111/phpp.12753. Epub 2021 Nov 18. PMID: 34773302.

3: Navarro-Triviño FJ, Ayén-Rodríguez Á, Llamas-Molina JM, Saenz-Guirado S,
Ruiz-Villaverde R. Treatment of superficial basal cell carcinoma with 7.8%
5-aminolaevulinic acid nanoemulsion-based gel (BF-200 ALA) and photodynamic
therapy: Results in clinical practice in a tertiary hospital. Dermatol Ther.
2021 Jan;34(1):e14558. doi: 10.1111/dth.14558. Epub 2020 Nov 27. PMID: 33210436.

Unidad de Melanomas/Oncología cutánea

Conservative nodal surgery (node-picking) of patients with stage III melanoma with low-burden of nodal disease (MELCONSURG MULTICENTRE COHORT)
Código: PI20/01217
Entidad Financiadora: Instituto Salud Carlos III
Promotor: Hospital Universitario Virgen Macarena. 
IP David Moreno Ramirez
SubI: Francisco Almazan Fernandez y Ricardo Ruiz Villaverde

Caracterización de las propiedades mecánicas in vivo de la piel normal frente a la sospechosa de tumores benignos y de melanoma y carcinoma escamoso y basocelular. ELASTOME
IP: José Luis Martín Rodríguez/Inas H.Faris/Guillermo Rus
Sub-I: Aurelio Martín Castro, Ricardo Ruiz Villaverde, Hirad Shamimi Noori, Jose M. Cortés, Jorge Torres

Abordaje de la salud oral y la calidad de vida en supervivientes de cáncer de cabeza y cuello mediante terapia de fotobiomodulación complementada con un sistema de m-health. estudio l3axer.
Código: PI -0187-2021
Entidad Financiadora: Consejería de salud y familias. Proyectos de investigación en salud de
temática general 2021.
Promotor: Grupo Cuidate UGR
Investigadoras Principales: Isabel Tovar Martin y Noelia Galiano Castillo
Duración: 36 meses
– Fecha de inicio: 09/12/2021
– Fecha de finalización prevista: 08/12/2024

Estudio de microARNs circulantes y parámetros de estrés oxidativo e inflamación como  biomarcadores en el carcinoma basocelular 
Código: 2022-Proyectos intramurales
Entidad Financiadora: Ibs. Instituto biosanitario de Granada
IP: Germaine Escamez
Promotor: UGR. MP17. Comunicación intracelular
Sub-I: Ricardo Ruiz Villaverde 

Dermatología General 

Título: Proyecto SSAD – Generación de cohortes y caracterización multiómica del Síndrome de Sjögren y la Dermatitis Atópica (código SSAD)
Carácter: Nacional
Código Proyecto: PR(AT)569/2021
Investigador principal: Jose Manuel Ruiz Carrascosa 
Co-investigador: Ricardo Ruiz Villaverde
Dedicación: Compartida

Caracterización histología y molecular de la matriz extracelular en la AAF. Estudio prospectivo, abierto, no controlado
Promotor: Servicio de Dermatología. Hospital Universitario Clínico San Cecilio
FEA: Ricardo Ruiz Villaverde y Francisco J Navarro Triviño
En activo 

Publicaciones: Carmona-Rodríguez M, Moro-Bolado F, Romero-Aguilera G, Ruiz-Villaverde R, Carriel V. Frontal Fibrosing Alopecia: An Observational Single-Center Study of 306 Cases. Life (Basel). 2023 Jun 8;13(6):1344. doi: 10.3390/life13061344. PMID: 37374126; PMCID: PMC10300830.

A prospective observational study of adult patients receiving Dupixent for atopic dermatitis
Protocol Number: OBS15990 / GLOBOSTAD
Investigador principal: Ricardo Ruiz Villaverde
En activo

Elaboración de un atlas celular diferenciado por sexo de tejido cutáneo en pacientes con esclerosis sistémica mediante secuenciación del transcriptoma de célula única.
Investigador Principal: Dra. Marialbert Acosta Herrera    
Hospital/Centro: Instituto de Investigación Biosanitaria de Granada. CSIC
Colaborador: Ricardo Ruiz Villaverde 

Estudio observacional para identificar las características clínicas, metodología diagnóstica, abordaje terapéutico y la comorbilidad vinculada al prurigo nodular en la práctica clínica
Promotor: Galderma
GAL-PN-2022-01
Investigador principal: Ricardo Ruiz Villaverde
Finalizado

Perspectiva del paciente respecto a la dermatitis atópica en España, estudio transversal y  ulticéntrico (3p-stADy)
Promotor: Abbvie
H24-077
Investigador principal: Ricardo Ruiz Villaverde
Finalizado

Real world utilization of upadacitinib in adult and adolescent patients living with moderate to severe atopic dermatitis (AD-VISE)
Promotor: Abbvie
Codigo: Protocolo P20-441
Investigador principal: José Carlos Ruiz Carrascosa
En Activo

Tralokinumab ReAl world Clinical usE An observational cohort study of atopic dermatitis patients prescribed tralokinumab
Promotor: Leo Pharma
Codigo: LEO Pharma_TRACE_NIS-TRALO-2213
Investigador principal: Ricardo Ruiz Villaverde 
Finalizado

A 24-Month Prospective Observational Cohort Study Evaluating Oral Systemic Therapies in the Management of Adult Patients with Atopic Dermatitis in REAL-World Practice (AD-REAL)
Promotor: Lilly
Codigo: Protocol I4V-MC-B026
Investigador principal: Ricardo Ruiz Villaverde 
Finalizado

Unidad de Psoriasis 

A multicenter, prospective observational RWE study to assess Patient-reported wellbeing using tildrakizumab in a live setting – POSITIVE Study
Promotor: Almirall
Codigo: M-14745-47
Investigador principal: José Carlos Ruiz Carrascosa
Finalizado
6 pacientes reclutados

ENSAYOS CLINICOS ACTIVOS 2024

Título: A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov Identifier: NCT03569293
Carácter: Europeo
Protocol Number: M18-891 y continuación: M16-047
Promotor: Abbvie SA
Investigador principal Local: Jose C Ruiz Carrascosa
Co-investigador: Ricardo Ruiz Villaverde
n= 6 y n=1
6 pacientes reclutados en el M18-891 pasará sólo 1 paciente al M16-047

Título: Psoriasis Longitudinal Assessment and Registry (PSOLAR). Registry C0168Z03. A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
Carácter: Europeo
Protocol Number: ClinicalTrials.gov Identifier: NCT00508547
Promotor: Janssen Scientific Affairs, LLC
Investigador principal: Jose Carlos Ruiz Carrascosa
Co-investigador: Ricardo Ruiz Villaverde
n=8

Título: A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
Carácter: Europeo
Protocol Number: ARGX-113-2009 y ARGX-113-2010
Promotor: Argenx BV
Investigador principal: David Moyano Bueno 
Co-investigador: Ricardo Ruiz- Villaverde
n=3
2 pacientes reclutados en el ARGX-113-2009 y 1 paciente reclutado en el ARGX-113-2010

Título: A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigo Protocol Number: ARGX-113-1904 Version Number: 1.0 (Original) Compound: Efgartigimod (ARGX-113) 
Carácter: Europeo
Protocol Number: ARGX-113-1904 y ARGX-113-1905
Promotor: Argenx BV
Investigador Principal: David Moyano Bueno
Co-investigador: Ricardo Ruiz Villaverde
n=3
2 pacientes reclutados en el ARGX-113-2009 y 1 paciente reclutado en el ARGX-113-2010

Título: A Phase 4, Multi-centre, Randomized, Evaluator[1]blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Evaluate the Long-term Safety of Tirbanibulin 10 mg/g Ointment and Diclofenac Sodium 3% Gel for the Treatment of Adult Patients with Actinic Keratosis on the Face or Scalp.
Carácter: Europeo
Protocol Number: M-14789-41
Promotor:Almirall, S.A.
Investigador principal: Ricardo Ruiz Villaverde
Co-investigador: Jose C Ruiz Carrascosa
n=8
12 pacientes reclutados

Título: A phase 3 clinical trial to evaluate efficacy and safety of twice daily applications of delgocitinib cream 20 mg/g compared with cream vehicle in adolescents 12-17 years of age with moderate to severe chronic hand eczema
Caracter: Europeo
Protocol number: LP0133-1426 
Promotor: Leo Pharma
Investigador Principal: Francisco J Navarro Triviño
Co-investigador: Ricardo Ruiz Villaverde
n=3
5 pacientes reclutados

Título: A single (assessor) blinded, randomized, parallel-group, monotherapy trial to evaluate the pharmacokinetics and safety of tralokinumab in children (age 2 to <12 years) with moderate-to-severe atopic dermatitis. 
Caracter: Europeo
Protocol number: LP0162-1335
Promotor: Leo Pharma
Investigador principal: Ricardo Ruiz Villaverde
Co-investigador: Jose C Ruiz Carrascosa
n=0
0 pacientes reclutados, cierre previsto a final de mayo 2024

Título: Randomised, double-blind, placebo-controlled, Phase IIb/Phase III study to evaluate the efficacy and safety of spesolimab in patients with moderate to severe hidradenitis suppurativa. Lunsayil 1.
Caracter: Europeo
Protocol Number: 1368-0098
Promotor: Boehringer-ingelheim.com
Investigador principal: Ricardo Ruiz Villaverde
Co-investigador: Jose C Ruiz Carrascosa
n=1
1 paciente reclutado

Título: Estudio en fase III, multicéntrico, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia y seguridad de JNJ-77242113 para el tratamiento de pacientes con psoriasis en placas en áreas especiales
Caracter: Europeo
Protocol Number:  77242113PSO3003
Promotor: Janssen
Investigador Principal Local: Jose Carlos Ruiz Carracosa
Co-investigador: Ricardo Ruiz Villaverde
1 paciente reclutado

Título: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Caracter: Europeo
Protocol Number:  77242113PSO3002
Promotor: Janssen
Investigador Principal Local: Jose Carlos Ruiz Carrascosa
Co-investigador: Ricardo Ruiz Villaverde
2 pacientes reclutados

Título: A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy (ADHAND). ClinicalTrials.gov 
Caracter: Europeo
Protocol Number: NCT05958407
Promotor: Leo Pharma
Investigador Principal: Francisco Navarro Triviño
Co-investigador: Pablo Velasco Amador
Título: Phase 2b, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Dose Finding study to evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GSK1070806 SC injection in Adult Participants with Moderate to Severe Atopic Dermatitis
Protocol Number: 219538  (AtDventure)
Promotor: Glaxo
Investigador Principal: Ricardo Ruiz Villaverde
Co-investigador: Jose Carlos Ruiz Carracosa
n=2 
2 pacientes reclutados

Título: Estudio en fase III, aleatorizado, controlado con placebo, doble ciego para evaluar la eficacia, seguridad y tolerabilidad de upadacitinib en sujetos adultos y adolescentes con vitíligo no segmentario que son aptos para recibir tratamiento sistémico
Caracter: Europeo
Protocol Number: M19-044
Promotor: Abbvie
Investigador Principal Local: Jose Carlos Ruiz Carracosa
Co-investigador: Ricardo Ruiz Villaverde
n=3
3 pacientes reclutados